Physician profile
Dora Richardson
NPI 1922037332
$2,601.99
in general payments reported to CMS, 2019-2025
22 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $850 · 2022: $443 · 2023: $656 · 2024: $497 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,309.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,309.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $686.12 | 2021-2025 | Farxiga, Lokelma, Airsupra |
| Lilly USA, LLC | $610.77 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Teva Pharmaceuticals USA, INC. | $214.30 | 2021-2023 | Austedo Xr |
| Novo Nordisk INC | $148.71 | 2021-2022 | |
| Organogenesis INC. | $136.10 | 2021-2023 | Puraply |
| Lundbeck LLC | $124.99 | 2024 | Vyepti |
| Abbvie INC. | $118.58 | 2021 | |
| Lucid Diagnostics INC. | $116.61 | 2024 | |
| Sanofi-Aventis U.S. LLC | $90.37 | 2024 | |
| Avanir Pharmaceuticals, INC. | $67.80 | 2021-2022 | |
| Mimedx Group, INC. | $57.65 | 2024-2025 | |
| Exact Sciences Corporation | $35.45 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Glaxosmithkline, LLC. | $32.49 | 2023-2024 | Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.40 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $26.82 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $19.67 | 2021 | |
| Pfizer INC. | $19.32 | 2023 | |
| Acella Pharmaceuticals, LLC | $16.52 | 2025 | NP Thyroid 60 |
| Abbott Laboratories | $13.59 | 2022 | |
| Grt US Holding, INC. | $12.15 | 2021 | |
| Esperion Therapeutics, INC. | $11.82 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $11.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dora Richardson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.